Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome

Chinese Journal of Integrative Medicine

Volumn 14, Issue 4, 2008, Pages 267-273

  Xue, Mei ^a   Chen, Ke Ji ^a   Yin, Hui Jun ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Blood stasis syndrome; Coronary heart disease; Gene polymorphism; GMP 140; GO II b IIIa; GP I b; Platelet activation

Indexed keywords

CD61 ANTIGEN; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IIB; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; BLOOD STASIS SYNDROME; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GENE LOCUS; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HEMATOLOGIC DISEASE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

CORONARY DISEASE; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATING FACTOR; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 57749168386     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-008-0267-1     Document Type: Article

References (10)

1. Chen HZ, ed. Practical internal medicine. 12th ed. Beijing: People's Medical Publishing House, 2005:1472-1473.
2. Society of Cardiology, Chinese Association of the Integration of Traditional and Western Medicine. The diagnostic criteria of TCM in coronary heart disease. Chin J Integr Tradit West Med (Chin) 1991;11(5):257.
3. Jackson SP, Schoenwaelder SM. Antiplatelet therapy: in search of the 'magic bullet'. Nat Rev Drug Discov 2003;2:775-789.
4. Rauch U, Osende JI, Fuster V, et al. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 2001; 134: 224-238.
5. Michelson AD, Barnard MR, Krueger LA, et al. Circulating monocyte- platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104: 1533-1537.
6. Zhang WG, Yan TX, Gao FJ, et al.Study on Effect of Zhixinkang Capsule in treating, unstable effort angina and hyperlipidemia and its function in vascular enclothelium protection. Chin J Integr Med 2003;9 (1): 25-30.
7. Liu ZG, Yu XY. Effects of Xuezhikang Capsule on blood lipids, platelet activation and coagulation-fibrinolysis activity in patients with hyperlipidemia. Chin J Integr Med 2004; 10(4):259-262.
8. Wang JZ, ed. Applications of flow cytometry in clinical researches. 1st ed. Shanghai: Shanghai Science and Technology Press, 2005: 237.
9. Tian XY, Liu ZZ, Zhang JL. Relationship between different coronary lesions of unstable angina pectoris and platelet GP II b-III a receptor expression. J Cardiovasc Pulmonary Dis (Chin) 2002;21(1):22-23.
10. Williams Ms, Ng'alla LS, Vaidya D, et al. Platelet functional implications of glycoprotein I balpha polymorphisms in African Americans. Am J Hematol 2007; 82:15-22.